Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Arthritis & Rheumatology (Hoboken, N.J.)|December 5, 2015
Lupus Nephritis IgG Induction of Calcium/Calmodulin-Dependent Protein Kinase IV Expression in Podocytes and Alteration of Their FunctionKunihiro Ichinose, Takeshi Ushigusa, Ayako Nishino, et al.
RMD Open|January 22, 2024
Human leucocyte antigens and Japanese patients with polymyalgia rheumatica: the protective effect of DRB1*09:01Shinichi Nogi, Shomi Oka, Takashi Higuchi, et al.
Arthritis Research & Therapy|July 24, 2020
Comparison of complete renal response and mortality in early- and late-onset lupus nephritis: a multicenter retrospective study of a Japanese cohortKunihiro Ichinose, Mineaki Kitamura, Shuntaro Sato, et al.
Frontiers in Immunology|January 30, 2018
M1 and M2 Monocytes in Rheumatoid Arthritis: A Contribution of Imbalance of M1/M2 Monocytes to OsteoclastogenesisShoichi Fukui, Naoki Iwamoto, Ayuko Takatani, et al.
Clinical Immunology (Orlando, Fla.)|October 9, 2018
Podocyte foot process width is a prediction marker for complete renal response at 6 and 12 months after induction therapy in lupus nephritisKunihiro Ichinose, Mineaki Kitamura, Shuntaro Sato, et al.
Plos One|May 5, 2017
Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritisNaoki Iwamoto, Sosuke Tsuji, Ayuko Takatani, et al.
Immunological Medicine|January 12, 2019
Efficacy of infliximab as a switched biologic in rheumatoid arthritis patients in daily clinical practiceMasataka Umeda, Tomohiro Koga, Kunihiro Ichinose, et al.
Clinical Immunology (Orlando, Fla.)|October 17, 2017
CD4+ CD52lo T-cell expression contributes to the development of systemic lupus erythematosusMasataka Umeda, Tomohiro Koga, Kunihiro Ichinose, et al.
Pageof 10